MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

    P. Hoff, F. Butt (Oklahoma City, USA)

    Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…
  • 2024 International Congress

    Prevalence and Spectrum of Movement Disorders in a Rural Neurology Clinic in Western India

    D. Desai, S. Udani, A. Shah, S. Desai (Anand, India)

    Objective: This study aimed to determine the prevalence and distribution of different movement disorder subtypes presenting to a rural neurology clinic. Background: Movement disorders constitute…
  • 2024 International Congress

    Parkinson Patients` Motor and Cognitive Functions are Improved by High Intensity LSVT®BIG Physiotherapy – a Randomized Prospective Pilot Trial

    B. Wimmer, B. Budeus, M. Katzer, C. Preiner, T. Wächter, K. Seppi, U. Bogdahn (Innsbruck, Austria)

    Objective: The objective of this pilot study was to evaluate the potential efficacy of high intensity physiotherapy LSVT®BIG on motor and non-motor functions of PD…
  • 2024 International Congress

    Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.

    D. Sharma, M. Nottage, W. Vallat, R. Wilcox, M. Tan, N. Liam, A. Dwyer (Adelaide, Australia)

    Objective: Evaluate the impact of 18F-DOPA PET/CT on clinical management for Parkinsonism. Background: Parkinson’s Disease affects >100,000 people in Australia with an economic burden of…
  • 2024 International Congress

    Prevalence of Heterozygous ATP7B Mutation in Patients with Movement Symptoms

    Y. Kim, D. Park, J. Yoon (Suwon, Republic of Korea)

    Objective: The objective of our study is to elucidate the prevalence of heterozygous ATP7B mutation in patients with movement symptoms. We aim to determine whether…
  • 2024 International Congress

    Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest of China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients

    YF. Cheng, HF. Shang (Chengdu, China)

    Objective: Objective: To summarize clinical characteristics, imaging features and genetic data of PLA2G6 mutant patients in southwest of China, and to investigate the heterogeneity between Asian and…
  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism

    G. Palermo, A. Francesconi, G. Bellini, R. Morganti, G. Migaleddu, D. Di Carlo, P. Perrini, N. Benedetto, C. Pacchetti, D. Volterrani, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the nigrostriatal pathway in iNPH patients with clinical parkinsonism, employing dopaminergic transporter (DAT) and nigrosome imaging. Background: Patients with idiopathic Normal Pressure…
  • 2024 International Congress

    Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism

    M. Acharya (Kharagpur, India)

    Objective: Using precise diagnostic criteria, the single-center observational study aims to evaluate the clinical profiles of non-IPD parkinsonism, specifically identifying crucial clinical clues for discriminating…
  • 2024 International Congress

    Perry Syndrome due to a DCTN1 novel variant

    P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

    Objective: To report the clinical features of a patient with Perry syndrome (PS) due to a heterozygous novel pathogenic variant in the DCTN1 gene. Background:…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley